Mini-ReviewResearch on Quality of Life in Female Patients with Congenital Adrenal Hyperplasia and Issues in Developing Nations
Introduction
Congenital adrenal hyperplasia (CAH), an autosomal recessive disorder, is caused by genetic impairment of one of the 5 enzymes required for the biosynthesis of cortisol from cholesterol in the adrenal cortex. The most frequent enzyme deficiency in CAH is steroid 21-hydroxylase deficiency (21-OHD), accounting for more than 90% of cases.1 The range of incidence for this condition is from 1:10,000 to 1:20,000 births and it is more prevalent in some ethnic groups (e.g., Alaskan Yupiks).2, 3, 4, 5 CAH is the commonest cause of ambiguous genitalia for female newborns and is one of several conditions under the umbrella term “Disorders of Sex Development” (DSD).
DSD refers to “congenital conditions in which the development of chromosomal, gonadal, or anatomic sex is atypical.”6 Management of DSDs require multidisciplinary collaboration and is challenging, to say the least. To date there has been a resurgence in research performed on these patients. One of the aspects of management brought up by those involved in the care of patients with DSDs are the need for more attention to be focused on the psychological aspects and quality of life of those affected.6, 7, 8 There is a paucity of long-term outcome studies on DSD to inform on whether current management achieves optimal outcome.9 This review on the research done on quality of life (QOL) of female patients with CAH aims to address the following issues: (1) to discuss possible factors affecting quality of life (QOL) of female patients with CAH, especially in the developing population; (2) to summarize the extant literature on the quality of life outcomes of female patients with CAH; and (3) to offer recommendations to improve QOL outcomes in clinical practice and research.
Section snippets
Clinical Factors
A spectrum of phenotypes can be seen in 21-OHD; from the severe classical salt-wasting (SW) form, to the classical less severe simple-virilizing (SV), and to the non-classical forms (NC-CAH) which manifest during early adolescence.10 All female patients with classical 21-OHD exhibit ambiguous external genitalia. Approximately two-thirds of patients with classical CAH due to 21-OHD have insufficient aldosterone biosynthesis, leading to salt-wasting crises postnatally.3 This is characterized by
Further Challenges Faced by Female CAH Patients in Developing Asian Nations
Added to the issues already mentioned, in several countries of the developing world, the CAH patients face poverty, ignorance, poor basic medical knowledge, lack of psychological services, and inadequate laboratory support, as well as lack of appropriate, affordable medications.82 Specialists in pediatric endocrinology are very few in number in many countries, including Malaysia. These countries do not have newborn screening programs; hence, late presentations and delayed diagnoses occur.
Quality of Life
In 1993, the World Health Organization defined quality of life (QOL) as “an individual's perception of their position in life in the context of the culture and value systems in which they live, and in relation to their goals, expectations, and standards and needs. It is a broad ranging concept affected in a complex way by the person's physical health, psychological state, level of independence, social relationships, and their relationships to salient features of their environment.”92 Quality of
Quality of Life Research Done on CAH patients
A summary of studies investigating quality of life of patients with CAH are shown in Table 1.47, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107 As can be seen, different research designs were employed; qualitative or quantitative or a combination of both. Many different questionnaires were used to assess quality of life in different studies; however, the Medical Outcomes Survey 36-item short form health survey (SF-36) was used in four of them.101, 102, 103, 104 The age ranges in these
Recommendations
The common recommendation is that CAH patients be managed by multidisciplinary teams in a tertiary center accessible to all comprising endocrinologists, gynecologists, geneticists, psychologists, pathologists, ethicists, urologists, specialist nurses, and even support groups.104, 105, 108, 109, 110 This provides for optimal care and will improve considerably the quality of lives of patients and their families. However, due to limited resources, the formation of these multidisciplinary teams in
Acknowledgments
The authors thank Dr. Srijit Das, Faculty of Medicine, UKM, for writing assistance and encouragement.
References (110)
Newborn screening for congenital adrenal hyperplasia
Endocrinol Metab Clin North Am
(2001)- et al.
Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development
Best Pract Res Clin Endocrinol Metab
(2007) Tissue-preserving feminizing clitoroplasty: a preliminary report
J Pediatr Urol
(2007)- et al.
Corporeal sparing dismembered clitoroplasty: an alternative technique for feminizing genitoplasty
J Urol
(2007) A new 1-stage procedure for clitorovaginoplasty in severely masculinized female pseudohermaphrodites
J Urol
(1989)- et al.
Transanorectal approach for the treatment of urogenital sinus: preliminary report
J Pediatr Surg
(1992) - et al.
Reconstruction of the high urogenital sinus: early perineal prone approach without division of the rectum
J Urol
(1997) Total urogenital mobilization–an easier way to repair cloacas
J Pediatr Surg
(1997)- et al.
Partial urogenital mobilization: a limited proximal dissection
J Pediatr Urol
(2006) - et al.
Early one-stage surgical reconstruction of the extremely high vagina in patients with congenital adrenal hyperplasia
J Pediatr Surg
(1994)
Neonatal management of female intersex by clitorovaginoplasty
J Urol
Surgical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am.
[Review]
Correction of congenital abnormalities of the vagina and perineum
J Pediatr Surg
Total urogenital sinus mobilization: a modified perineal approach for feminizing genitoplasty and urogenital sinus repair
J Urol
Congenital adrenal hyperplasia: preliminary observations of the urethra in 9 cases
J Urol
Use of the mobilized sinus with total urogenital mobilization
J Urol
Early intervention of CAH surgical management
J Pediatr Adolesc Gynecol
Feminizing genitoplasty [comment]
J Urol
Single-stage feminization genitoplasty
J Urol
A unified approach to early reconstructive surgery of the child with ambiguous genitalia
J Urol
Feminizing genitoplasty: a synthesis
J Urol
Repair of the high vagina in girls with severely masculinized anatomy from the adrenogenital syndrome
J Pediatr Surg
Long-term outcome of vaginal reconstruction: comparing techniques and timing
J Pediatr Urol
Results from a pediatric surgical centre justify early intervention in disorders of sex development
J Pediatr Surg
Ambiguous genitalia: an overview of 17 years’ experience
J Pediatr Surg
The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross- sectional study
Lancet
Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood
Lancet
Disorders of sexual differentiation
Endocrinol Metab Clin North Am
Gender assignment and the pediatric urologist. J Urol
[Comment Editorial]
Congenital adrenal hyperplasia
Lancet
1-Stage feminizing genitoplasty: 8 years of experience with 49 cases
J Urol
Vaginal reconstruction for ambiguous genitalia and congenital absence of the vagina: a 27-year experience
J Pediatr Surg
The complications of surgery for intersex: changing patterns over two decades
J Pediatr Surg
Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty?
J Urol
Congenital adrenal hyperplasia. I: Gender-related behavior and attitudes in female patients and sisters
Psychoneuroendocrinology
Congenital adrenal hyperplasia. II: Gender-related behavior and attitudes in female salt-wasting and simple-virilizing patients
Psychoneuroendocrinology
Gender change from female to male in classical congenital adrenal hyperplasia
Horm Behav
Psychosexual development of women with congenital adrenal hyperplasia
Horm Behav
Adult erotosexual status and fetal hormonal masculinization and demasculinization: 46, XX congenital virilizing adrenal hyperplasia and 46, XY androgen-insensitivity syndrome compared
Psychoneuroendocrinology
Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia
Psychoneuroendocrinology
Congenital adrenal hyperplasia
N Engl J Med
Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening
Horm Res
Current status of neonatal screening for congenital adrenal hyperplasia
Curr Opin Pediatr
Neonatal screening for congenital adrenal hyperplasia
Eur J Endocrinol
International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology: Consensus statement on management of intersex disorders. International Consensus Conference on Intersex
Pediatrics
Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues
Clin Endocrinol (Oxf)
Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Rev Endocr Metab Disord
Growth and development: congenital adrenal hyperplasia-glucocorticoids and height
Nat Rev Endocrinol
Prevention of ambiguous genitalia by prenatal treatment with dexamethasone in pregnancies at risk for congenital adrenal hyperplasia
Pure Appl Chem
Cited by (0)
The authors indicate no conflicts of interest.